‘Ebenezer’ Reviews: Johnny Depp’s Scrooge Comeback Splits Critics
- The Scoop: Paramount’s Ti West-directed Dickens adaptation Ebenezer lands a divided critical verdict, holding a 51% positive Rotten Tomatoes score ahead of its Nov. 13 theatrical bow.
- Performance & Prosthetics: Johnny Depp’s heavily made-up Scrooge draws praise as a return to his signature theatrical eccentricity, alongside complaints that the turn is anything but subtle.
- Box-Office Stakes: Tracking projects roughly $20 million domestic and $20 million overseas across 63 international markets for the opening frame.
Paramount Pictures’ gothic A Christmas Carol rework Ebenezer has drawn a mixed-to-frosty critical verdict, with Johnny Depp’s Scrooge splitting reviewers ahead of a Nov. 13 worldwide launch.
The Ti West-directed adaptation arrives with a 51% positive Rotten Tomatoes tally, a genuinely contested number rather than a collapse. That ambiguity now hands Paramount a marketing problem and an opportunity in the same weekend.
Prosthetics and Theatricality: Depp’s Scrooge Draws Cheers and Groans
West, working from Nathaniel Halpern’s screenplay, stages Dickens’ 1843 novella as horror-tinged material rather than cozy fireside fare. The film opens with a prologue tracing how Jacob Marley became a ghost, then jumps seven years into Scrooge’s loan office.
Depp’s transformation leans hard on extensive makeup and prosthetics, a choice both review camps fixate on. One assessment credited him with “the sort of quirky theatrical performance for which he became famous,” while conceding the work is not remotely subtle.
Variety’s notice read warmer, calling the film a “wickedly fun holiday treat” and a “strong comeback vehicle for its star.” That split verdict is the defining tension of the campaign.
The supporting ensemble carries real weight against Depp’s scenery-chewing center. Ian McKellen inhabits Jacob Marley, Rupert Grint takes Bob Cratchit, and Andrea Riseborough, Sam Claflin, Daisy Ridley and Tramell Tillman round out a cast built to lend prestige ballast to a star-driven spectacle.
Paramount’s Holiday Bet: Why the Calendar Does the Heavy Lifting
Paramount slots the film roughly six weeks before Christmas, planting it squarely in the seasonal corridor where Dickens’ ghost story has lived for over a century. The date trades on familiarity rather than any federal holiday weekend anchor.
Opening projections sit near $20 million domestic and a matching $20 million overseas, a modest frame for a studio release carrying a major star’s return. The film unfurls across 63 international markets day-and-date, widening the net fast.
This marks Depp’s first major Hollywood studio vehicle since 2018’s Fantastic Beasts: The Crimes of Grindelwald, making the opening frame a referendum on his commercial draw. The picture is not a franchise entry; its entire proposition rests on star persona and public-domain recognition.
That reliance cuts both ways. A divided critical reception gives Paramount cover to sell spectacle and sentiment over reviews, while the holiday window offers long-tail play through December if word of mouth holds.
Competitive positioning matters here, with rival action fare like the expanding martial-arts slate crowding multiplex screens this season. Every screen allocated to Ebenezer is a calculated wager on Depp’s pull.
The economics hinge on whether a 51% score translates into curiosity or caution. Paramount’s holiday play needs the seasonal pull to convert casual moviegoers before the Christmas crush reshuffles the calendar, all tracked across our theatrical release desk.
For Depp, the stakes are career-defining; for West, a genre pivot away from his horror pedigree; for Paramount, a bet that star wattage and Dickens still sell tickets. The Nov. 13 numbers will settle the argument the critics could not.